CELLULAR THERAPY RESEARCH & PRODUCTION
PetCell
Pioneering Regenerative Science for Animals
PetCell stands as a forward-looking biotechnology company focused on regenerative veterinary medicine, bringing innovation, specialized development, and scientific expertise into animal healthcare. As a Mexican company born from ITC (Institute of Cellular Therapy), it reflects a strong foundation in research, cellular applications, and advanced therapeutic development for veterinary use.
PetCell's strength resides in the development and application of mesenchymal stem cells and NK cell therapies, including advanced approaches for oncology treatments. As the only brand commercializing species-specific, animal-origin cellular therapies, PetCell delivers tailored regenerative solutions for dogs, cats, and horses.
Supported by a licensed laboratory platform and a model built around quality, safety, and clinical innovation, PetCell stands as a distinctive leader in veterinary regenerative medicine, expanding the possibilities of advanced care through science-driven solutions.
Veterinary Regenerative Medicine
PART OF
Sani Capital Ecosystem
CAPABILITIES
Areas of Expertise
Development and application of species-specific mesenchymal stem cell therapies for regenerative treatment in companion animals.
Mesenchymal Stem Cell Therapies
Advanced NK cell therapy approaches including oncology-focused treatments for dogs, cats, and horses.
NK Cell Therapies & Oncology